Story perspectives

Psychedelic DOI Shows Promise in Treating Depression

11/9/2025

41 4

Summary

Story summary

A study suggests the psychedelic compound DOI may rewire the brain and aid depression treatment.
Researchers studied how these substances affect neurons linked to thought and emotion, mapping claustrum and anterior cingulate cortex.
The study highlights anxiety and depression in the U.S., with 18.2% and 21.4% of adults reporting symptoms.
Unlike traditional antidepressants, psychedelics may provide faster, longer-lasting relief, though they remain Schedule I while Oregon has legalized therapeutic use.

1 of 1

Story summary

A study suggests the psychedelic compound DOI may rewire the brain and aid depression treatment.
Researchers studied how these substances affect neurons linked to thought and emotion, mapping claustrum and anterior cingulate cortex.
The study highlights anxiety and depression in the U.S., with 18.2% and 21.4% of adults reporting symptoms.
Unlike traditional antidepressants, psychedelics may provide faster, longer-lasting relief, though they remain Schedule I while Oregon has legalized therapeutic use.